180 Additional treatment does not improve the survival of locally advanced or metastatic NSCLC patients who responded after two courses of cisplatin (C), vindesin (V), mitomycin (M) chemotherapy
- 31 August 1997
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: